Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis.

Wojciechowski, Jessica; Malhotra, Bimal K; Wang, Xiaoxing; Fostvedt, Luke; Valdez, Hernan; Nicholas, Timothy

Wojciechowski, Jessica; Malhotra, Bimal K; Wang, Xiaoxing; Fostvedt, Luke; Valdez, Hernan; Nicholas, Timothy.

Afiliación

Wojciechowski J; Department of Global Product Development, Pfizer Inc., Groton, CT, USA. Jessica.Wojciechowski@pfizer.com.
Malhotra BK; Department of Global Product Development, Pfizer Inc., New York, NY, USA.
Wang X; Department of Global Product Development, Pfizer Inc., Groton, CT, USA.
Fostvedt L; Department of Global Product Development, Pfizer Inc., Cambridge, MA, USA.
Valdez H; Department of Global Product Development, Pfizer Inc., New York, NY, USA.
Nicholas T; Department of Global Product Development, Pfizer Inc., Groton, CT, USA.

Clin Pharmacokinet ; 61(4): 591, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35178675

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google